Arcutis enrolls first patient in ARQ-234 atopic dermatitis trial




Arcutis enrolls first patient in ARQ-234 atopic dermatitis trial



Source link

  • Related Posts

    Dycom Industries Q4 2026 Earnings Preview

    Dycom Industries Q4 2026 Earnings Preview Source link

    Subscribe to read

    To read this article for free Register now Once registered, you can: • Read free articles • Get our Editor’s Digest and other newsletters • Follow topics and set up…

    Leave a Reply

    Your email address will not be published. Required fields are marked *